ArticlePLoS neglected tropical diseases2026
Addressing the elephant in the room: Proceedings of the third annual Dengue Endgame Summit.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue is a disease caused by four serologically and genetically distinct orthoflaviviruses spread by mosquitoes. It is the largest arthropod-borne viral disease in the world with millions of human cases each year. The third annual Dengue Endgame Summit was convened in Syracuse, New York, over August 12-14, 2025, to discuss the current state of dengue, global dengue control efforts, and paths towards achieving sustained and effective dengue control. The event brought together 181 participants from 48 institutions across 11 countries to address current dengue outbreaks, next-generation mosquito vector interventions, vaccine and antiviral development, immune correlates of protection, and human challenge models. Four key themes emerged from the in-depth and nuanced discussions at the summit: (1) dengue control will require globally coordinated but locally tailored approaches that account for regional transmission differences and diverse circulating viral serotypes and genotypes; (2) the evolving dengue burden necessitates the strategic deployment of countermeasures, including vaccines, antivirals, and vector control, matched to local epidemiology; (3) longstanding dogma surrounding dengue immunopathogenesis and immune correlates of protection should be systematically reevaluated in light of advances in our understanding of cellular immunity, trained innate immunity, and the interplay of multiple components of the immune response; and (4) sustained progress depends on multisectoral collaboration, adequate financial resources, political commitment, and integration with broader vector-borne disease control efforts. These discussions highlighted both the complexity of dengue control and the diverse opportunities for accelerating progress toward a dengue endgame.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.